Axelife's mission is to improve cardiovascular prevention and quality of life through clinically validated medical devices and innovative algorithms at the service of healthcare professionals and patients. Axelife markets an innovative medical device, pOpmetre, clinically validated and recommended by scientific societies, which predicts in a few seconds the cardiovascular risk for patients There are now 33 scientific publications on pOpmetre in the fields of pulse wave velocity and vascular aging, central aortic pressure as well as PAD.